Kathleen Scott - Chief Financial Officer at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kathleen Scott - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Kathleen Scott for ARS Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10K $151K $15.00 Aug 21, 2025 Direct
Common Stock 8.25K $106K $12.86 Aug 21, 2025 By Scott 2008 Trust Dated 3/28/08
Stock Option (Right to Buy) 740K Aug 21, 2025 Direct Common Stock

Transactions reported by Kathleen Scott for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.